Mmcap International Inc. Spc Inhibrx, Inc. Transaction History

Mmcap International Inc. Spc

  • $516 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$32.76 - $39.56 $14.8 Million - $17.9 Million
451,433 New
451,433 $15.8 Million

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Mmcap International Inc. Spc Portfolio

Follow Mmcap International Inc. Spc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mmcap International Inc. Spc, based on Form 13F filings with the SEC.

News

Stay updated on Mmcap International Inc. Spc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email